nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—PRKCA—adrenal medulla—adrenal gland cancer	0.14	0.418	CbGeAlD
Ingenol Mebutate—PRKCA—brown adipose tissue—adrenal gland cancer	0.0807	0.241	CbGeAlD
Ingenol Mebutate—PRKCD—adrenal cortex—adrenal gland cancer	0.0245	0.0732	CbGeAlD
Ingenol Mebutate—PRKCD—gonad—adrenal gland cancer	0.0203	0.0607	CbGeAlD
Ingenol Mebutate—PRKCD—pituitary gland—adrenal gland cancer	0.0198	0.0592	CbGeAlD
Ingenol Mebutate—PRKCD—adrenal gland—adrenal gland cancer	0.0177	0.0529	CbGeAlD
Ingenol Mebutate—PRKCA—gonad—adrenal gland cancer	0.0112	0.0334	CbGeAlD
Ingenol Mebutate—PRKCA—pituitary gland—adrenal gland cancer	0.0109	0.0326	CbGeAlD
Ingenol Mebutate—PRKCA—adrenal gland—adrenal gland cancer	0.00977	0.0291	CbGeAlD
Ingenol Mebutate—PRKCD—Hemostasis—SPARC—adrenal gland cancer	0.000945	0.00142	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—PRKACA—adrenal gland cancer	0.00094	0.00141	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—SH3KBP1—adrenal gland cancer	0.000936	0.00141	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways in Glioblastoma—CDKN2A—adrenal gland cancer	0.000914	0.00137	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—SPARC—adrenal gland cancer	0.000913	0.00137	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Insulin Signaling—IGF1R—adrenal gland cancer	0.000909	0.00137	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Wnt Signaling Pathway—CTNNB1—adrenal gland cancer	0.000899	0.00135	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—CDC42—adrenal gland cancer	0.000892	0.00134	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling events mediated by VEGFR1 and VEGFR2—CTNNB1—adrenal gland cancer	0.000888	0.00134	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways in Glioblastoma—TP53—adrenal gland cancer	0.000886	0.00133	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—CDC42—adrenal gland cancer	0.000884	0.00133	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—BRAF—adrenal gland cancer	0.000882	0.00133	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—ZNRF3—adrenal gland cancer	0.00088	0.00132	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—MEN1—adrenal gland cancer	0.000872	0.00131	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB1 downstream signaling—BRAF—adrenal gland cancer	0.000868	0.00131	CbGpPWpGaD
Ingenol Mebutate—PRKCD—ErbB1 downstream signaling—EGFR—adrenal gland cancer	0.000866	0.0013	CbGpPWpGaD
Ingenol Mebutate—PRKCD—BDNF signaling pathway—CTNNB1—adrenal gland cancer	0.000849	0.00128	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB Signaling Pathway—EGFR—adrenal gland cancer	0.000846	0.00127	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Thromboxane A2 receptor signaling—EGFR—adrenal gland cancer	0.000822	0.00124	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Apoptosis—CTNNB1—adrenal gland cancer	0.0008	0.0012	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—PRKACA—adrenal gland cancer	0.000797	0.0012	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.000794	0.00119	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000788	0.00118	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—RB1—adrenal gland cancer	0.000777	0.00117	CbGpPWpGaD
Ingenol Mebutate—PRKCA—PDGFR-beta signaling pathway—BRAF—adrenal gland cancer	0.000755	0.00114	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.000755	0.00114	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	0.000754	0.00113	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—BAD—adrenal gland cancer	0.000753	0.00113	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—BAD—adrenal gland cancer	0.000745	0.00112	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Wnt Signaling Pathway and Pluripotency—TP53—adrenal gland cancer	0.000744	0.00112	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neuronal System—PRKACA—adrenal gland cancer	0.000737	0.00111	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	0.000726	0.00109	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—PRKACA—adrenal gland cancer	0.000723	0.00109	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—BAD—adrenal gland cancer	0.000721	0.00108	CbGpPWpGaD
Ingenol Mebutate—PRKCA—AGE/RAGE pathway—EGFR—adrenal gland cancer	0.000721	0.00108	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—PRKACA—adrenal gland cancer	0.000718	0.00108	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000715	0.00108	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB Signaling Pathway—TP53—adrenal gland cancer	0.000711	0.00107	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—GNRHR—adrenal gland cancer	0.000705	0.00106	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000702	0.00106	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Corticotropin-releasing hormone—CTNNB1—adrenal gland cancer	0.000698	0.00105	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Mitotic Prophase—RB1—adrenal gland cancer	0.000694	0.00104	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—adrenal gland cancer	0.00069	0.00104	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000686	0.00103	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—BRAF—adrenal gland cancer	0.000678	0.00102	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—BAD—adrenal gland cancer	0.000678	0.00102	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—CDC42—adrenal gland cancer	0.000676	0.00102	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—BAD—adrenal gland cancer	0.000674	0.00101	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—BAD—adrenal gland cancer	0.000671	0.00101	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—BAD—adrenal gland cancer	0.000668	0.001	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000656	0.000986	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signaling of activated FGFR—EGFR—adrenal gland cancer	0.000654	0.000984	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—IGF2—adrenal gland cancer	0.000652	0.00098	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—GNAS—adrenal gland cancer	0.000646	0.000972	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Wnt Signaling Pathway and Pluripotency—CTNNB1—adrenal gland cancer	0.000642	0.000966	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—PTGS2—adrenal gland cancer	0.000639	0.000961	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—TSHR—adrenal gland cancer	0.000638	0.000959	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—BAD—adrenal gland cancer	0.000628	0.000945	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—BAD—adrenal gland cancer	0.000628	0.000945	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—BAD—adrenal gland cancer	0.000622	0.000936	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFA-VEGFR2 Pathway—CTNNB1—adrenal gland cancer	0.000618	0.00093	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—BAD—adrenal gland cancer	0.000617	0.000928	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000617	0.000927	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signal transduction—EGFR—adrenal gland cancer	0.000615	0.000925	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—BAD—adrenal gland cancer	0.000614	0.000924	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—BRAF—adrenal gland cancer	0.000614	0.000923	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—BRAF—adrenal gland cancer	0.000614	0.000923	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Oncostatin M Signaling Pathway—TP53—adrenal gland cancer	0.000613	0.000921	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR—EGFR—adrenal gland cancer	0.000612	0.00092	CbGpPWpGaD
Ingenol Mebutate—PRKCD—EGF/EGFR Signaling Pathway—EGFR—adrenal gland cancer	0.000612	0.00092	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by ERBB2—EGFR—adrenal gland cancer	0.000609	0.000916	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—CDC42—adrenal gland cancer	0.000609	0.000916	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways in Glioblastoma—EGFR—adrenal gland cancer	0.000606	0.000911	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 signaling—EGFR—adrenal gland cancer	0.000606	0.000911	CbGpPWpGaD
Ingenol Mebutate—PRKCD—MAPK Signaling Pathway—EGFR—adrenal gland cancer	0.000594	0.000894	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.000591	0.000889	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—CTNNB1—adrenal gland cancer	0.000583	0.000878	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—SH3KBP1—adrenal gland cancer	0.000583	0.000876	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—BRAF—adrenal gland cancer	0.000572	0.00086	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 interactions—EGFR—adrenal gland cancer	0.00057	0.000857	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR in disease—EGFR—adrenal gland cancer	0.00057	0.000857	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—MED12—adrenal gland cancer	0.00057	0.000857	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR—EGFR—adrenal gland cancer	0.000565	0.00085	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR in Cancer—EGFR—adrenal gland cancer	0.00056	0.000842	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by PDGF—EGFR—adrenal gland cancer	0.000557	0.000838	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—BAD—adrenal gland cancer	0.000556	0.000837	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—SPRY2—adrenal gland cancer	0.000552	0.00083	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—TOP2A—adrenal gland cancer	0.000549	0.000826	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—NR5A1—adrenal gland cancer	0.000545	0.000819	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—MEN1—adrenal gland cancer	0.000545	0.000819	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—SPARC—adrenal gland cancer	0.000543	0.000816	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—SH3KBP1—adrenal gland cancer	0.000538	0.000809	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Apoptosis—TP53—adrenal gland cancer	0.000532	0.0008	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—SDHB—adrenal gland cancer	0.00053	0.000797	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.000519	0.00078	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways in Glioblastoma—TP53—adrenal gland cancer	0.000509	0.000765	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—BRAF—adrenal gland cancer	0.000506	0.000762	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—ZNRF3—adrenal gland cancer	0.000506	0.000761	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—MEN1—adrenal gland cancer	0.000506	0.000761	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—EGFR—adrenal gland cancer	0.000505	0.000759	CbGpPWpGaD
Ingenol Mebutate—PRKCD—MAPK Signaling Pathway—TP53—adrenal gland cancer	0.000499	0.000751	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB1 downstream signaling—EGFR—adrenal gland cancer	0.000497	0.000748	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—TOP2A—adrenal gland cancer	0.000491	0.000738	CbGpPWpGaD
Ingenol Mebutate—PRKCA—beta-catenin independent WNT signaling—CTNNB1—adrenal gland cancer	0.00049	0.000737	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.000488	0.000734	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—PRKACA—adrenal gland cancer	0.000483	0.000727	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—PRKACA—adrenal gland cancer	0.000458	0.000689	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000458	0.000688	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—TERT—adrenal gland cancer	0.000453	0.000681	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—EGFR—adrenal gland cancer	0.000453	0.000681	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000452	0.00068	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.000435	0.000654	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—PRKACA—adrenal gland cancer	0.000432	0.00065	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—BAD—adrenal gland cancer	0.000428	0.000644	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000427	0.000643	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Wnt Signaling Pathway and Pluripotency—TP53—adrenal gland cancer	0.000427	0.000643	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—BAD—adrenal gland cancer	0.000425	0.000639	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—GNRH1—adrenal gland cancer	0.000423	0.000636	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—PRKACA—adrenal gland cancer	0.000418	0.000629	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—PRKACA—adrenal gland cancer	0.000412	0.00062	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000411	0.000618	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000408	0.000614	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—GNRHR—adrenal gland cancer	0.000405	0.000609	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000403	0.000606	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neuronal System—BRAF—adrenal gland cancer	0.000397	0.000598	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—EGFR—adrenal gland cancer	0.000393	0.000591	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—BRAF—adrenal gland cancer	0.00039	0.000586	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.000389	0.000585	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—CDC42—adrenal gland cancer	0.000388	0.000584	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—EGFR—adrenal gland cancer	0.000388	0.000584	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—CDC42—adrenal gland cancer	0.000388	0.000584	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SPRY2—adrenal gland cancer	0.000386	0.000581	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PRKACA—adrenal gland cancer	0.000386	0.000581	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—TP53—adrenal gland cancer	0.00038	0.000572	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000377	0.000566	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TSHR—adrenal gland cancer	0.000377	0.000566	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—EGFR—adrenal gland cancer	0.000376	0.000565	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—IGF2—adrenal gland cancer	0.000374	0.000563	CbGpPWpGaD
Ingenol Mebutate—PRKCA—M Phase—RB1—adrenal gland cancer	0.000373	0.000562	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—GNAS—adrenal gland cancer	0.000371	0.000558	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—GNAS—adrenal gland cancer	0.000371	0.000558	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—TSHR—adrenal gland cancer	0.000366	0.000551	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CDC42—adrenal gland cancer	0.000355	0.000533	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MEN1—adrenal gland cancer	0.000354	0.000533	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000354	0.000533	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—EGFR—adrenal gland cancer	0.000353	0.000531	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—EGFR—adrenal gland cancer	0.000351	0.000529	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—EGFR—adrenal gland cancer	0.000351	0.000529	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—EGFR—adrenal gland cancer	0.00035	0.000526	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CDC42—adrenal gland cancer	0.00035	0.000526	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—EGFR—adrenal gland cancer	0.000348	0.000523	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Mitotic M-M/G1 phases—RB1—adrenal gland cancer	0.000342	0.000515	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—RRM1—adrenal gland cancer	0.000341	0.000513	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—SDHD—adrenal gland cancer	0.000341	0.000513	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CDC42—adrenal gland cancer	0.000327	0.000492	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—EGFR—adrenal gland cancer	0.000327	0.000492	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—EGFR—adrenal gland cancer	0.000327	0.000492	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—MED12—adrenal gland cancer	0.000327	0.000492	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—EGFR—adrenal gland cancer	0.000324	0.000488	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—EGFR—adrenal gland cancer	0.000322	0.000484	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—EGFR—adrenal gland cancer	0.00032	0.000482	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—SPRY2—adrenal gland cancer	0.000317	0.000477	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—MEN1—adrenal gland cancer	0.000313	0.00047	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	0.000308	0.000463	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—TERT—adrenal gland cancer	0.000294	0.000442	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MEN1—adrenal gland cancer	0.00029	0.000437	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—EGFR—adrenal gland cancer	0.00029	0.000436	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.00028	0.000421	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—CTNNB1—adrenal gland cancer	0.00028	0.00042	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—POMC—adrenal gland cancer	0.000275	0.000414	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PRKACA—adrenal gland cancer	0.00027	0.000407	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000263	0.000395	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—TERT—adrenal gland cancer	0.000263	0.000395	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—CTNNB1—adrenal gland cancer	0.000259	0.00039	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	0.000259	0.000389	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—RB1—adrenal gland cancer	0.000256	0.000385	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—MED12—adrenal gland cancer	0.000255	0.000383	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—POMC—adrenal gland cancer	0.00025	0.000376	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—BAD—adrenal gland cancer	0.000247	0.000372	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000245	0.000369	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—BAD—adrenal gland cancer	0.000244	0.000367	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—GNRH1—adrenal gland cancer	0.000243	0.000365	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PRKACA—adrenal gland cancer	0.00024	0.000361	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000235	0.000353	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CDC42—adrenal gland cancer	0.000229	0.000345	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—RB1—adrenal gland cancer	0.000229	0.000344	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—BAD—adrenal gland cancer	0.000228	0.000344	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	0.000225	0.000338	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—EGFR—adrenal gland cancer	0.000223	0.000335	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CDC42—adrenal gland cancer	0.000223	0.000335	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SPRY2—adrenal gland cancer	0.000222	0.000334	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PRKACA—adrenal gland cancer	0.000222	0.000333	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—EGFR—adrenal gland cancer	0.000221	0.000333	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IGF2—adrenal gland cancer	0.000221	0.000332	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—GNAS—adrenal gland cancer	0.000219	0.00033	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TSHR—adrenal gland cancer	0.000216	0.000325	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IGF1R—adrenal gland cancer	0.000214	0.000321	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—GNAS—adrenal gland cancer	0.000213	0.00032	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—BRAF—adrenal gland cancer	0.000208	0.000313	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—TP53—adrenal gland cancer	0.000207	0.000311	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CDC42—adrenal gland cancer	0.000204	0.000306	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MEN1—adrenal gland cancer	0.000203	0.000306	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CDKN2A—adrenal gland cancer	0.000201	0.000303	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CDC42—adrenal gland cancer	0.000188	0.000283	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PRKACA—adrenal gland cancer	0.000186	0.000279	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TERT—adrenal gland cancer	0.000184	0.000277	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PTGS2—adrenal gland cancer	0.000168	0.000253	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CTNNB1—adrenal gland cancer	0.000163	0.000245	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CTNNB1—adrenal gland cancer	0.000161	0.000241	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—BAD—adrenal gland cancer	0.00016	0.000241	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—POMC—adrenal gland cancer	0.000158	0.000238	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PRKACA—adrenal gland cancer	0.000155	0.000233	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—TERT—adrenal gland cancer	0.000151	0.000227	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GNAS—adrenal gland cancer	0.00015	0.000226	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CTNNB1—adrenal gland cancer	0.00015	0.000226	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ABCB1—adrenal gland cancer	0.000148	0.000222	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—POMC—adrenal gland cancer	0.000148	0.000222	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—BRAF—adrenal gland cancer	0.000146	0.000219	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—POMC—adrenal gland cancer	0.000143	0.000216	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—BAD—adrenal gland cancer	0.000142	0.000214	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—EGFR—adrenal gland cancer	0.000141	0.000212	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CDC42—adrenal gland cancer	0.000132	0.000198	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—BAD—adrenal gland cancer	0.000131	0.000197	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—EGFR—adrenal gland cancer	0.000129	0.000194	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—EGFR—adrenal gland cancer	0.000127	0.000191	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IGF2—adrenal gland cancer	0.000127	0.000191	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—GNAS—adrenal gland cancer	0.000126	0.000189	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IGF1R—adrenal gland cancer	0.000123	0.000185	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—BRAF—adrenal gland cancer	0.000119	0.00018	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—EGFR—adrenal gland cancer	0.000119	0.000179	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—TP53—adrenal gland cancer	0.000119	0.000178	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—TP53—adrenal gland cancer	0.000112	0.000168	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TERT—adrenal gland cancer	0.000106	0.000159	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000105	0.000158	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—POMC—adrenal gland cancer	0.000101	0.000152	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PTGS2—adrenal gland cancer	9.65e-05	0.000145	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CTNNB1—adrenal gland cancer	9.35e-05	0.000141	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—BAD—adrenal gland cancer	9.19e-05	0.000138	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CTNNB1—adrenal gland cancer	8.63e-05	0.00013	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—POMC—adrenal gland cancer	8.47e-05	0.000127	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—BRAF—adrenal gland cancer	8.37e-05	0.000126	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—EGFR—adrenal gland cancer	8.34e-05	0.000125	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—EGFR—adrenal gland cancer	8.11e-05	0.000122	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PTGS2—adrenal gland cancer	8.08e-05	0.000122	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—EGFR—adrenal gland cancer	7.41e-05	0.000111	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TP53—adrenal gland cancer	7e-05	0.000105	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—EGFR—adrenal gland cancer	6.84e-05	0.000103	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CTNNB1—adrenal gland cancer	6.05e-05	9.09e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—EGFR—adrenal gland cancer	4.79e-05	7.2e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TP53—adrenal gland cancer	4.02e-05	6.05e-05	CbGpPWpGaD
